158 related articles for article (PubMed ID: 33637374)
21. Cellularity and cartilage matrix increased in hypertrophied ligamentum flavum: histopathological analysis focusing on the mechanical stress and bone morphogenetic protein signaling.
Shafaq N; Suzuki A; Terai H; Wakitani S; Nakamura H
J Spinal Disord Tech; 2012 Apr; 25(2):107-15. PubMed ID: 21430570
[TBL] [Abstract][Full Text] [Related]
22. Increased sorbitol levels in the hypertrophic ligamentum flavum of diabetic patients with lumbar spinal canal stenosis.
Luo J; Huang L; Chen Z; Zeng Z; Miyamoto T; Wu H; Zhang Z; Pan Z; Fujita N; Hikata T; Iwanami A; Tsuji T; Ishii K; Nakamura M; Matsumoto M; Watanabe K; Cao K
J Orthop Res; 2017 May; 35(5):1058-1066. PubMed ID: 27208686
[TBL] [Abstract][Full Text] [Related]
23. Quantitative analysis of transforming growth factor-beta 1 in ligamentum flavum of lumbar spinal stenosis and disc herniation.
Park JB; Chang H; Lee JK
Spine (Phila Pa 1976); 2001 Nov; 26(21):E492-5. PubMed ID: 11679833
[TBL] [Abstract][Full Text] [Related]
24. Increased advanced glycation end products in hypertrophied ligamentum flavum of diabetes mellitus patients.
Maruf MH; Suzuki A; Hayashi K; Habibi H; Salimi H; Terai H; Tamai K; Hoshino M; Toyoda H; Yamada K; Takahashi S; Ohyama S; Hori Y; Nakamura H
Spine J; 2019 Oct; 19(10):1739-1745. PubMed ID: 31195134
[TBL] [Abstract][Full Text] [Related]
25. Angiopoietin-like protein 2 promotes inflammatory conditions in the ligamentum flavum in the pathogenesis of lumbar spinal canal stenosis by activating interleukin-6 expression.
Nakamura T; Okada T; Endo M; Nakamura T; Oike Y; Mizuta H
Eur Spine J; 2015 Sep; 24(9):2001-9. PubMed ID: 25735609
[TBL] [Abstract][Full Text] [Related]
26. Role of Epiligament in Ligamentum Flavum Hypertrophy in Patients with Lumbar Spinal Canal Stenosis:a Pilot Study.
Sato N; Higashino K; Sakai T; Terai T; Goel VK; Biyani A; Ebraheim N; Takata Y; Hayashi F; Yamashita K; Morimoto M; Manabe H; Sairyo K
J Med Invest; 2018; 65(1.2):85-89. PubMed ID: 29593200
[TBL] [Abstract][Full Text] [Related]
27. GSK-3β and β-Catenin Signaling Pathway is Involved in Myofibroblast Transition of Ligamentum Flavum in Lumbar Spinal Stenosis Patients.
Shin HK; Seo KJ; Lee JY; Jeon SR; Yune TY
Spine (Phila Pa 1976); 2023 Oct; 48(20):1472-1479. PubMed ID: 37417723
[TBL] [Abstract][Full Text] [Related]
28. Hypertrophy and Fibrosis of the Ligamentum Flavum in Lumbar Spinal Stenosis is Associated With Increased Expression of LPA and LPAR1.
Zhang K; Sun W; Liu XY; Zhao CQ; Li H; Sun XJ; You-Zhuan X; Ding W; Zhao J
Clin Spine Surg; 2017 Apr; 30(3):E189-E191. PubMed ID: 28323698
[TBL] [Abstract][Full Text] [Related]
29. Hypertrophy of ligamentum flavum in lumbar spine stenosis is associated with increased miR-155 level.
Chen J; Liu Z; Zhong G; Qian L; Li Z; Qiao Z; Chen B; Wang H
Dis Markers; 2014; 2014():786543. PubMed ID: 24963214
[TBL] [Abstract][Full Text] [Related]
30. Hypertrophy of the ligamentum flavum in lumbar spinal canal stenosis is associated with abnormal accumulation of specific lipids.
Yamada T; Horikawa M; Sato T; Kahyo T; Takanashi Y; Ushirozako H; Kurosu K; Al Mamun M; Mihara Y; Oe S; Arima H; Banno T; Yosida G; Hasegawa T; Yamato Y; Matsuyama Y; Setou M
Sci Rep; 2021 Dec; 11(1):23515. PubMed ID: 34873238
[TBL] [Abstract][Full Text] [Related]
31. ACSM5 inhibits ligamentum flavum hypertrophy by regulating lipid accumulation mediated by FABP4/PPAR signaling pathway.
Cao Y; Li J; Qiu S; Ni S; Duan Y
Biol Direct; 2023 Nov; 18(1):75. PubMed ID: 37957699
[TBL] [Abstract][Full Text] [Related]
32. miR-29b-3p Affects the Hypertrophy of Ligamentum Flavum in Lumbar Spinal Stenosis and its Mechanism.
Zhang H; Hong Z; Jiang Z; Hu W; Hu J; Zhu R
Biochem Genet; 2024 Apr; ():. PubMed ID: 38625592
[TBL] [Abstract][Full Text] [Related]
33. Chondrogenic and fibrotic process in the ligamentum flavum of patients with lumbar spinal canal stenosis.
Yabe Y; Hagiwara Y; Ando A; Tsuchiya M; Minowa T; Takemura T; Honda M; Hatori K; Sonofuchi K; Kanazawa K; Koide M; Sekiguchi T; Itoi E
Spine (Phila Pa 1976); 2015 Apr; 40(7):429-35. PubMed ID: 25627290
[TBL] [Abstract][Full Text] [Related]
34. The Role of JAK-STAT Signaling Activation in Hypertrophied Ligamentum Flavum.
Delen E; Doğanlar O; Delen Ö; Doğanlar ZB; Kılınçer C
World Neurosurg; 2020 May; 137():e506-e516. PubMed ID: 32059970
[TBL] [Abstract][Full Text] [Related]
35. CCN5 Reduces Ligamentum Flavum Hypertrophy by Modulating the TGF-β Pathway.
Ye S; Kwon WK; Bae T; Kim S; Lee JB; Cho TH; Park JY; Kim K; Hur JK; Hur JW
J Orthop Res; 2019 Dec; 37(12):2634-2644. PubMed ID: 31334871
[TBL] [Abstract][Full Text] [Related]
36. The Role of Smad2 in Transforming Growth Factor β
Wang L; Chang M; Tian Y; Yan J; Xu W; Yuan S; Zhang K; Liu X
World Neurosurg; 2021 Jul; 151():e128-e136. PubMed ID: 33831616
[TBL] [Abstract][Full Text] [Related]
37. Pathomechanism of loss of elasticity and hypertrophy of lumbar ligamentum flavum in elderly patients with lumbar spinal canal stenosis.
Kosaka H; Sairyo K; Biyani A; Leaman D; Yeasting R; Higashino K; Sakai T; Katoh S; Sano T; Goel VK; Yasui N
Spine (Phila Pa 1976); 2007 Dec; 32(25):2805-11. PubMed ID: 18246001
[TBL] [Abstract][Full Text] [Related]
38. Impact of oxidized LDL/LOX-1 system on ligamentum flavum hypertrophy.
Nagai S; Hachiya K; Takeda H; Ikeda D; Kawabata S; Watanabe K; Kaneko S; Fujita N
J Orthop Sci; 2023 May; 28(3):669-676. PubMed ID: 35123844
[TBL] [Abstract][Full Text] [Related]
39. Hypertrophy of the ligamentum flavum in lumbar spinal canal stenosis is associated with increased bFGF expression.
Honsawek S; Poonpukdee J; Chalermpanpipat C; Payungporn S; Limthongkul W; Yingsakmongkol W; Thanakit V; Parkpian V
Int Orthop; 2013 Jul; 37(7):1387-92. PubMed ID: 23519824
[TBL] [Abstract][Full Text] [Related]
40. Circular RNA Expression Profile in Patients with Lumbar Spinal Stenosis Associated with Hypertrophied Ligamentum Flavum.
Chen J; Yu X; Qiu M; Feng F; Liu Z; Zhong G
Spine (Phila Pa 1976); 2021 Sep; 46(17):E916-E925. PubMed ID: 33534519
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
